-transparent.png){kind=logo}
A group of 243 patients with mycosis fungoides (MF) received treatment with topical applications of dilute aqueous solutions of mechlorethamine and/or systemic chemotherapy over the past 10 years. The likelihood of a complete and relapse-free remission and survival was found to correlate inversely to the magnitude of disease as denoted by a simple staging system. Although disease-free intervals of greater than 3 years have occurred thus far in 32 (13%) patients, the permanency of these remissions and the curability of disease remain uncertain because of the variability of disease progression characteristic of MF. Comparison of treatment results with those published on a large group of patients treated with total-skin electron-beam radiation therapy indicates that the chemotherapeutic approach to the treatment of MF is equally effective in promoting survival.
E C Vonderheid, and
E J Van Scott, and
P E Wallner, and
W C Johnson
March 1982,
Archives of dermatology,
E C Vonderheid, and
E J Van Scott, and
P E Wallner, and
W C Johnson
April 1992,
American journal of clinical oncology,
E C Vonderheid, and
E J Van Scott, and
P E Wallner, and
W C Johnson
April 1997,
Blood,
E C Vonderheid, and
E J Van Scott, and
P E Wallner, and
W C Johnson
December 1977,
Cancer,
E C Vonderheid, and
E J Van Scott, and
P E Wallner, and
W C Johnson
November 1977,
The British journal of dermatology,
E C Vonderheid, and
E J Van Scott, and
P E Wallner, and
W C Johnson
September 1978,
Cancer,
E C Vonderheid, and
E J Van Scott, and
P E Wallner, and
W C Johnson
April 1979,
Cancer treatment reports,
E C Vonderheid, and
E J Van Scott, and
P E Wallner, and
W C Johnson
October 1988,
Journal of the American Academy of Dermatology,
E C Vonderheid, and
E J Van Scott, and
P E Wallner, and
W C Johnson
February 2019,
Clinical lymphoma, myeloma & leukemia,
E C Vonderheid, and
E J Van Scott, and
P E Wallner, and
W C Johnson
December 1973,
Radiology,
